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Thirty Years of Environmental
Health Research - And Growing
This month, the National Institute of Environmental Health
Sciences marks 30 years-the anniversary of a reorganization that
led to the creation of the National Institute of Environmental
Health Sciences within the National Institutes ofHealth. We cele-
brate our progress from a time, as one Governor ofNorth Carolina
remarked, when there were more possums on our Research
Triangle campus than Ph.D.s.
The environmental health sciences have made great progr
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Over the past 20 years using the tools of recombinant DNA
technology, researchers have identified a number ofgenes involved
in the development of specific diseases such as cystic fibrosis and
sickle cell anemia. These discoveries have been of the single gene
variety (an alteration in just one gene causes a disease). Today we
seek the causes and prevention of more common diseases such as
cancer, Alzheimer's, Parkinson's, and osteoporosis that appear to
arise from a complex interplay between inherited genetic alter-
ations and the environment, rather than from a single gene.
Challenge: Teasing apart the causes of disease. Before we
can prevent or improve the treatment of most diseases, we need a
better understanding of individual function of critical genes
involved in the growth and development ofhumans and the ability
of environmental agents to interact with and damage these genes.
Analyzing these complexities and teasing apart the genetic and envi-
ronmental components involved represents a daunting challenge and
an important scientific opportunity. The tools and technology devel-
oped by molecular geneticists are being used by environmental
health scientists to help in the discovery ofgenes modulated by the
environment.
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anism ofaction.
Challenge: Using animal models to understand human dis-
ease. Technical advances have always played a key role in improving
our ability to prevent and treat disease and are equally important in
the discovery process in environmental health research. Technical
advances in mouse genetics have now overcome an important
impediment in biomedical research: the lack of animal models in
which to study the development ofhuman diseases. Recently devel-
oped methods in animal genetics allow the study ofdiseases in a way
that was impossible when this Institute was created 30 years ago.
These new techniques provide the remarkable ability to introduce
mutations into the genetic material of mice that can be passed to
their offspring. Investigators can now insert any mutation they
choose into the mouse genome. They can also transfer genes from
one animal species to another, and they can express genes at a differ-
ent time and in different tissue than normal. Researchers are on the
verge ofcreating the three most important animal models needed to
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determine the role ofthe environment in the development ofbreast
and ovarian cancers.
For example, researchers at NIEHS have developed a "knock-
out" mouse that lacks the estrogen receptor. The female hormone
estrogen directs and controls cell growth and differentiation by bind-
ing to the estrogen receptor located in tissues throughout the body.
Many environmental compounds bind to these same receptors, thus,
potentially acting as environmental estrogens. These environmental
compounds may play a role in a wide range ofdiseases. In women,
they may be implicated in the development ofendometriosis, uterine
fibroids, and cancers ofthe breast, uterus, and ovaries. In men, these
compounds might explain the increase in testicular cancer, the
decline in sperm count, and other reproductive tract anomalies.
Also, with the recent isolation of the human breast cancer suscepti-
bility genes BRCA1 and BRCA2 (with major contributions by
NIEHS scientists), efforts are under way to create "knock-out" and
transgenic mouse models for these genes.
Challenge: Developing new animal models for testing. We
also have the opportunity to develop new models for use in carcino-
genicity and toxicity testing. Existing measures ofcarcinogenicity are
based largely on rodent bioassays in which mice are fed large amounts
of a single chemical. Human diets, in contrast, consist of small
amounts ofseveral natural and synthetic chemicals. These differences
in exposures raise considerable uncertainties about whether the data
derived from animal tests can be applied directly to humans.
Uncertainties also result from variations among species and among
individuals due to differences in age, gender, socioeconomic status,
and genetic predisposition. Moreover, the current rodent bioassay for
assessing carcinogenicity is too costly ($2-6 million per chemical,
depending on the route ofexposure) and too time consuming (taking
up to five years to plan, conduct, interpret, andcertify).
I am pleased to report that genetically engineered mice and in
vitro assays have been developed that could become the new standard
for carcinogenicity testing. The genetic alterations were designed to
provide results faster, with fewer animals and less expense, than the
current cancer bioassay. While it is still uncertain as to what extent
these models can be used in lieu ofthe two-year rodent bioassay, the
best guess is that they will greatly reduce our dependency on this
assay, with considerable savings in both time and cost. Also, the new
models may be more relevant to human risk assessment in terms of
dosimetry, mechanism, and genetic background. While there are rea-
sons for excitement concerning the potential impact that these geneti-
cally engineered models can have on environmental health research, it
is important to emphasize that they represent only the first genera-
tion; better models will be developed!
Though the scientific challenges are daunting, rapid advances in
a number offields offer great promise. As more becomes known, it
will be possible to develop regulatory policies based on a better
understanding of how environmental agents affect human health.
Continued research will eventually provide answers for many ofthe
difficult questions about the link between environment and human
health.
To summarize, environmental health research is at the crossroads
oftremendous change. With the advent ofsophisticated tools ofcell
and molecular biology, researchers can now obtain more rigorous
data about the environmental effects on human health. It is no
longer adequate to assume exposures; it is time that the putative
exposures be quantified and their health effects documented. This
information will be invaluable to physicians and public health offi-
cials in preventing, diagnosing, and treating disease. It will also assist
policy makers in decisions about risk and regulatory responses, and
the research may help clarify the influence that behavior and socioe-
conomic status have on human susceptibility to environmental
agents with carcinogenic or toxic potential.
Thanks to the vision and hard work ofmany, including particu-
larly Institute directors Paul Kotin and David P. Rall and Nobel
Laureate Martin Rodbell, the foundation built during NIEHS' first
30 years is broad, solid, and distinguished. Since 1991, as the third
director of NIEHS, I have seen the creativity and dedication of
Institute personnel. I have been proud oftheir prizes and discoveries
and ofthe benefits that flow from these discoveries for the diagnosis,
treatment, and, especially, the prevention of disease. I believe these
extraordinary achievements will not only continue but will quickly
overshadow what has gone before.
The problems are enormous, the questions exciting-and the
solution will require enthusiasm, creativity, and hard work. But the
answers will come.
Kenneth Olden
National Institute ofEnvironmental Health Sciences and the
NationalToxicologyProgram ofthe National Institutes ofHealth
Environmental Mutagen Society A
The 28th Annual Environmental Mutagen Society Meeting will be held at the Hyatt Regency Hotel in Minneapolis,
Minnesota, April 19-24, 1997. The Environmental Mutagen Society is an international society whose purpose is to engage in
scientific investigation and dissemination ofinformation relating to the field ofmutagenesis and to encourage the study of
mutagens in the human environment in particular, how mutagens may affect public health. The annual
meeting brings together scientists from academia, industry, and government to discuss recent findings in the fields of muta-
genesis and molecular genetics and their application to regulation and safety evaluation.
For more information, please contact Sid Aaron, Pharmacia and Upjohn Inc., 301 Henrietta St., Kalamazoo, MI 49007;
(616) 833-1399, Fax (616) 833-9722, email: saaron@am.pnu.com or the EMS business office, 11250-8 Roger Bacon Dr., Suite 8,
Reston, VA 22090; (703) 437-4377, Fax (703) 435-4390, email: emsdmg@aol.com
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